Hormones and Hair Loss: the Medical Management of Androgenetic Alopecia in the Presence of Androgen Replacement Therapy - Single Course

Hormones and Hair Loss: the Medical Management of Androgenetic Alopecia in the Presence of Androgen Replacement Therapy - Single Course is organized by Age Management Medicine Group (AMMG).

Release Date: September 15, 2019
Expiration Date: September 15, 2020

Accreditation:
This Course has been approved for a maximum of 1.0 CME Credits

Description:
Hereditary hair loss or Androgenetic Alopecia affects approximately 40 million men in the United States. In 2017 it was estimated that 2.3 million American men receive testosterone replacement therapy. Numerous clinical trials have supported and confirmed that the progression of hair loss is an often-unwanted sign of aging and a significant trigger for decreased Quality of Life in the affected population. In men, the chronic progressive miniaturization of hair follicles and hair loss in response to an inherited sensitivity to endogenous, normal levels of dihydrotestosterone (DHT) can begin to occur soon after puberty, and eventually affecting more than half of all men by the time they age to 50. Because DHT, the primary trigger for androgenetic alopecia, is created from testosterone through the 5-alpha reductase pathway, actions/activities and treatments that are designed to beneficially replace or enhance testosterone levels are often associated with accelerated hereditary hair loss as DHT levels rise. Unwanted, unexpected and accelerated hair loss may be a barrier for continued androgen replacement therapy, resulting in patient’s cessation of therapy. An understanding of the stratagems used to elucidate risk factors, diagnose, measure/monitor signs and symptoms, as well as the initiation of therapeutic interventions for Androgenetic Alopecia, can be used to avoid and-or manage this increasingly common unintended and unwanted consequence of androgen replacement therapy and ensure continued patient compliance with their androgen replacement therapy regimen.

Learning Objectives:
• Learn and understand the evidence-based theory of Interventional Endocrinology and the science behind and clinical applications of hormone therapy for patients who have been property assessed and diagnosed as deficient.
• Learn and understand the science and protocols in properly assessing patients who may have a hormone deficiency.
• Learn and understand the latest evidence-based research in the field of hormones and hormone replacement.
• Learn and understand the latest evidence-based Literature and Clinical Information on Estrogen Dominance.
• Learn and understand the signs and symptoms of adrenal fatigue & suboptimal thyroid and understand how to diagnose oververt endocrine disorders of the adrenal and thyroid.
• Learn and understand the signs of “estrogen dominance/progesterone deficiency,” when and how to measure levels, and the benefits of various delivery systems
• Learn and understand the latest evidence-based benefits and risks of bio-identical HRT and understand clinically based techniques to make this HRT more reliable and more successful.
• Learn and understand the latest evidence-based stratagems used to elucidate risk factors, diagnose, measure/monitor signs and symptoms, as well understanding therapeutic interventions for Androgenetic Alopecia.
• Learn and understand essentials of an Age Management BHRT program.
• Learn and understand the evidence-based theory of Interventional Endocrinology and the science behind and clinical applications of hormone therapy for patients who have been property assessed and diagnosed as deficient.